Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study.
The mapping and sequencing of the human genome promises rapid growth in understanding the genetically influenced mechanisms that underlie human disease. To realize this promise fully, it is necessary to relate genetic information to clinical phenotypes. Genetic tissue banking in clinical studies provides opportunities to analyze the genetic contribution to variation in response to treatments. The challenges to progress are likely to come from the complex organizational, social, political, and ethical issues that must be resolved in order to put clinical and DNA bank information together. Concerns about subjects' rights, informed consent, privacy, and ownership of genetic material require attention in the development of DNA banks. In this paper we describe one approach to the solution of these problems that was adopted by one clinical trials group, the Department of Veterans Affairs Cooperative Studies Program.
Lavori
Philip W
PW
Palo Alto VA Health Care System, Palo Alto, CA, USA. lavori@odd.stanford.edu
Krause-Steinrauf
Heidi
H
Brophy
Mary
M
Buxbaum
Joel
J
Cockroft
Jennifer
J
Cox
David R
DR
Fiore
Louis
L
Greely
Henry T
HT
Greenberg
Harry
H
Holmes
Edward W
EW
Nelson
Lorene M
LM
Sugarman
Jeremy
J
D002986:Clinical Trials as Topic / Q000379:methods*; D004992:Ethics, Medical; D015894:Genome, Human; D005838:Genotype; D006801:Humans; D007258:Informed Consent; D014015:Tissue Banks / Q000458:organization & administration*; D014481:United States; D014493:United States Department of Veterans Affairs